Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker MDLZ · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance… NCT06479330 · Gastrointestinal Tolerance, Healthy Population Milk Chocolate | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 60 | Oct 16, 2024 | Registry ↗ |
| Apr 1, 2026 | Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients NCT03847701 · Type2 Diabetes Balanced diet high in Slowly Digestible Starch, Balanced di… | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 53 | Nov 15, 2024 | Registry ↗ |
| Mar 27, 2026 | Evaluating the Impact of Fat and Sugar Replacer Blends on Gastrointestinal Tolerance in Biscuits NCT07372482 · Gastrointestinal Tolerance, Healthy Population Test sandwiched biscuits with creme, Control sandwiched bis… | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 56 | Feb 27, 2026 | Registry ↗ |
| Feb 13, 2026 | Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammator… NCT07408479 · Insulin Resistance Balanced diet high in Slowly Digestible Starch and Resistan… | MDLZ Mondelēz International, Inc. | Not applicable | Recruiting | 40 | Dec 2027 | Registry ↗ |
| Sep 8, 2023 | Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance… NCT05827198 · Gastrointestinal Tolerance, Healthy Population Low-sugar candies compared to regular sugar candies | MDLZ Mondelēz International, Inc. | Not applicable | Unknown | 60 | Dec 22, 2023 | Registry ↗ |
| Apr 3, 2023 | Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance NCT05794100 · Tolerance, Healthy Population Acute intake of one of the products (active comparator 1 to… | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 60 | May 30, 2022 | Registry ↗ |
| Oct 18, 2021 | Impact of Chewing Gum With CPP-ACP on Tooth Mineralisation in Situ NCT03971084 · Tooth Demineralization Sugar free gum without CPP-ACP, Sugar free gum with CPP-ACP | MDLZ Mondelēz International, Inc. | Not applicable | Unknown | 14 | Jun 2022 | Registry ↗ |
| May 27, 2020 | Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2… NCT03289494 · Type2 Diabetes Balanced diet high in Slowly Digestible Starch, Balanced di… | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 9 | Jul 24, 2018 | Registry ↗ |
| Jan 31, 2019 | Blood Glucose and Insulin Responses to Snack Food Products NCT01341769 · Study Focus 1:Glycaemic Index, Study Focus 2:Glycaemic Resp… Dietary Intervention, Dietary Intervention | MDLZ Mondelēz International, Inc. | Not applicable | Withdrawn | 0 | Jun 2011 | Registry ↗ |
| Sep 14, 2017 | Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products NCT02650674 · Metabolic Disorder Product A: NP-0148, Glucose solution | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 24 | Mar 2016 | Registry ↗ |
| Sep 14, 2017 | Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content Cons… NCT02538653 · Metabolic Disorder; Carbohydrate, Absorption, Intestine Sandwich biscuit high in SDS, Co-extruded cereal low in SDS | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 20 | Dec 2015 | Registry ↗ |
| Sep 14, 2017 | Plasma Glucose Kinetics and Cereal Product Content in Slowly Digestible Starch (SDS) in Healthy Vol… NCT02323542 · Blood Glucose Kinetics Nutrition intervention with cereal products | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 41 | Dec 2015 | Registry ↗ |
| Nov 2, 2015 | Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content and… NCT02538640 · Metabolism and Nutrition Disorders High-SDS biscuit, Low-SDS extruded cereals | MDLZ Mondelēz International, Inc. | Not applicable | Completed | 20 | Oct 2015 | Registry ↗ |
13 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 7:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances